Developing new methods to create complex molecules for drug development
Site-Selective Catalysis for Bioactive Scaffold Diversification
['FUNDING_OTHER'] · YALE UNIVERSITY · NIH-11090414
This study is working on new ways to create better medicines by using special techniques to change important molecules, which could lead to improved treatments for patients.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | YALE UNIVERSITY (nih funded) |
| Locations | 1 site (NEW HAVEN, UNITED STATES) |
| Trial ID | NIH-11090414 on ClinicalTrials.gov |
What this research studies
This research focuses on creating innovative catalysts that can selectively modify complex molecules, which are essential for developing new drugs. By exploring various chemical reactions involving common functional groups found in bioactive agents, the project aims to generate new analogs that could lead to improved therapeutic options. The approach includes the use of advanced techniques such as photochemical and electrochemical processes, enhancing the efficiency and effectiveness of drug synthesis. Patients may benefit from the resulting new drug candidates that could arise from these advancements.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would be individuals with conditions that could be treated by new drug therapies developed from these complex molecules.
Not a fit: Patients with conditions that are not addressed by the types of drugs being developed in this research may not receive any benefit.
Why it matters
Potential benefit: If successful, this research could lead to the development of new and more effective drug candidates for various medical conditions.
How similar studies have performed: Other research in the field of selective catalysis has shown promising results, indicating that this approach has the potential for significant breakthroughs in drug development.
Where this research is happening
NEW HAVEN, UNITED STATES
- YALE UNIVERSITY — NEW HAVEN, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MILLER, SCOTT J — YALE UNIVERSITY
- Study coordinator: MILLER, SCOTT J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.